Grant of Options

Fevertree Drinks PLC
07 May 2024
 

7 May 2024

Fevertree Drinks plc

Grant of Options

Fevertree Drinks plc (the "Company") announces the grant of options over a total of 252,436 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company with an exercise price of 0.25 pence.

On 3 May 2024, the following options were issued to the Company's Executive Directors, pursuant to the Company's Long Term Incentive Plan ("LTIP"):

 

Name

Title

Number of share options granted

Performance period

Vesting Date

Exercise price

Tim Warrillow

Chief Executive Officer

150,133

1 January 2024 to 31 December 2026

3 May 2027

0.25p per share

Andy Branchflower

Chief Financial Officer

102,303

1 January 2024 to 31 December 2026

3 May 2027

0.25p per share

 

The number of Ordinary Shares stated is the maximum number that could be issued to each Executive Director upon full satisfaction of the performance conditions attached to the 2024 awards.

 

Ends

 

For further information:

 

Investor queries

Ann Hyams, Director of Investor Relations I ann.hyams@fever-tree.com I +44 (0)2045 168 106

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

 

Nominated Advisor and Broker - Investec Bank plc

David Flin I +44 (0)20 7597 5970

 

Corporate Broker - Morgan Stanley & Co. International plc

Andrew Foster I Jessica Pauley I +44 (0)20 7425 8000

 

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171 I Anjali Unnikrishnan +44 (0)7826 534 233

 

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 85 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulations

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

1. Tim Warrillow

2. Andy Branchflower

2

Reason for the notification

a)

Position/status

1.   Chief Executive Officer

2.   Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Fevertree Drinks plc

b)

LEI

2138007AJRLHRVQZLD07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.25 pence each

 

Identification code

GB00BRJ9BJ26

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Exercise Prices per share

Volumes


1. 0.25p

2. 0.25p

1. 150,133

2. 102,303

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

3 May 2024

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
Investor Meets Company
UK 100